CD95 ligand expression in dedifferentiated breast cancer

por Moers, C, Müschen, M, Beckmann, MW, Mallmann, P
Publicado 2001

CD95 ligand expression mediates immune escape in breast cancer

por Moers, C, Müschen, M, Beckmann, MW, Mallmann, P
Publicado 2001

Resistance to CD95-mediated apoptosis in breast cancer is not due to somatic mutation of the CD95 gene

por Moers, C, Müschen, M, Beckmann, MW, Mallmann, P
Publicado 2001

Detection of circulating tumour cells in patients with breast or ovarian cancer by molecular cytogenetics

por Engel, H, Kleespies, C, Friedrich, J, Breidenbach, M, Kallenborn, A, Schöndorf, T, Kolhagen, H, Mallmann, P
Publicado 1999

Strong evidence that the common variant S384F in BRCA2 has no pathogenic relevance in hereditary breast cancer

por Wappenschmidt, B, Fimmers, R, Rhiem, K, Brosig, M, Wardelmann, E, Meindl, A, Arnold, N, Mallmann, P, Schmutzler, RK
Publicado 2005

Serological Her2/neu-determination in patients receiving Herceptin(®)

por Thomas, A, Hoopmann, M, Schöndorf, T, Neumann, R, Mallmann, P, Göhring, U-J, Kurbacher, CM, Eisberg, C, Tanasale, T, Warm, M
Publicado 2001